RNA Therapeutic for ADOA | Eye Disease
PYC Therapeutics
This video provides an overview of autosomal dominant optic atrophy (ADOA) and the mechanism of action (MoA) of PYC’s mRNA therapeutic candidate, PYC-001.
This video provides an overview of autosomal dominant optic atrophy (ADOA) and the mechanism of action (MoA) of PYC’s mRNA therapeutic candidate, PYC-001.